FDA Inspection 969376 — Ascensia Diabetes Cares US Inc.
The FDA completed an inspection of Ascensia Diabetes Cares US Inc. on Mar 2, 2016 in Parsippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 2, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Parsippany, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)